• OPEN AN ACCOUNT
Indian Indices
Sensex
74,529.08 -329.91
( -0.44%)
Global Indices
Nasdaq
51,895.24 -174.59
(-0.34%)
Dow Jones
7,786.35 0.65
(0.01%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,723.15 -15.86
(-0.15%)
Forex
USD-INR
95.99 0.12
(0.12%)
EUR-INR
110.24 0.24
(0.22%)
GBP-INR
128.54 0.36
(0.28%)
JPY-INR
0.61 0.00
(-0.53%)

EQUITY - MARKET SCREENER

Chandra Bhagat Pharma Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
542934
INE07QQ01016
43.9048511
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
12.24
37.31
EPS(TTM)
Face Value()
Div & Yield %
4.04
10
0
 

Uflex consolidated net profit rises 16.28% in the March 2026 quarter
Jun 01,2026
Net profit of Uflex rose 16.28% to Rs 196.02 crore in the quarter ended March 2026 as against Rs 168.57 crore during the previous quarter ended March 2025. Sales rose 4.70% to Rs 3954.67 crore in the quarter ended March 2026 as against Rs 3777.06 crore during the previous quarter ended March 2025.

For the full year,net profit rose 122.81% to Rs 317.10 crore in the year ended March 2026 as against Rs 142.32 crore during the previous year ended March 2025. Sales rose 1.47% to Rs 15063.51 crore in the year ended March 2026 as against Rs 14845.15 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3954.673777.06 5 15063.5114845.15 1
OPM %14.7710.86 -12.3511.15 -
PBDT428.20288.21 49 1195.361120.75 7
PBT219.59111.90 96 408.25425.88 -4
NP196.02168.57 16 317.10142.32 123